Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000541240 | SCV000629349 | likely benign | Retinoblastoma | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763900 | SCV000894836 | uncertain significance | Bone osteosarcoma; Malignant tumor of urinary bladder; Small cell lung carcinoma; Retinoblastoma | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017932 | SCV001179099 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001017932 | SCV002530866 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-26 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV000541240 | SCV004825623 | likely benign | Retinoblastoma | 2024-02-05 | criteria provided, single submitter | clinical testing |